⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29090360 | 0.97 | — | — | |
| SCHEMBL6259643 | 0.74 | CA5A (0.36) | — | |
| SCHEMBL6831155 | 0.71 | — | — | |
| SCHEMBL1896275 | 0.69 | — | — | |
| SCHEMBL30315 | 0.69 | — | — | |
| SCHEMBL11294604 | 0.69 | PTGS1 (0.32) | — | |
| SCHEMBL1177707 | 0.67 | — | — | |
| SCHEMBL1621912 | 0.67 | — | — | |
| SCHEMBL4817810 | 0.67 | — | — | |
| SCHEMBL3661846 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060141632-A1 | New methods and kits for sequencing polypeptides | THE PROCTER & GAMBLE CO. | 2006-06-29 | — | — | US | claimed |
| EP-1356297-A2 | METHODS AND KITS FOR SEQUENCING POLYPEPTIDES | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-29 | — | — | EP | claimed |
| WO-2002008767-A2 | METHODS AND KITS FOR SEQUENCING POLYPEPTIDES | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-31 | — | — | WO | claimed |
| EP-1145012-A2 | METHODS AND KITS FOR SEQUENCING POLYPEPTIDES | The Procter & Gamble Company (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000043792-A2 | METHODS AND KITS FOR SEQUENCING POLYPEPTIDES | THE PROCTER & GAMBLE COMPANY (US) | 2000-07-27 | — | — | WO | claimed |
| US-4196211-A | ANTIBIOTIC | MERCK & CO., INC. (US) | 1980-04-01 | — | — | US | claimed |
| US-4115378-A | TEXTILES | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-19 | — | — | US | claimed |
| US-9107953-B2 | Sustained release composition containing SDF-1 | ONO PHARMACEUTICAL CO., LTD. (JP) | 2015-08-18 | — | — | US | disclosed |
| US-20130243824-A1 | SUSTAINED RELEASE COMPOSITION CONTAINING SDF-1 | ONO PHARMACEUTICAL CO., LTD. (JP) | 2013-09-19 | — | — | US | disclosed |
| US-8435953-B2 | Sustained release composition containing SDF-1 | Tabata, Yasuhiko (JP) | 2013-05-07 | — | — | US | disclosed |
| EP-2218459-B1 | SUSTAINED RELEASE COMPOSITION CONTAINING SDF-1 | ONO PHARMACEUTICAL CO (JP) | 2012-02-01 | — | — | EP | disclosed |
| CN-101981197-A | Method for dercemisation of enantiomeric mixtures | EVONIK DEGUSSA GMBH | 2011-02-23 | — | — | CN | disclosed |
| US-20100267612-A1 | SUSTAINED RELEASE COMPOSITION CONTAINING SDF-1 | Tabata, Yasuhiko (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-0456039-A2 | Renin inhibiting amino acid derivatives | MERCK PATENT GmbH (DE) | 1991-11-13 | — | — | EP | disclosed |
| EP-0446751-A1 | Glycolic acid derivatives | MERCK PATENT GmbH (DE) | 1991-09-18 | — | — | EP | disclosed |
| EP-0446485-A2 | Peptide analogues with renininhibiting activity | MERCK PATENT GmbH (DE) | 1991-09-18 | — | — | EP | disclosed |
| EP-0418696-A2 | Derivatives of aminoacids | MERCK PATENT GmbH (DE) | 1991-03-27 | — | — | EP | disclosed |
| CN-1037155-A | Amino acid derivative | MERCK PATENT GMBH (DE) | 1989-11-15 | — | — | CN | disclosed |
| EP-0339483-A2 | Renin inhbiting amino-acid derivatives | MERCK PATENT GmbH (DE) | 1989-11-02 | — | — | EP | disclosed |
| EP-0337334-A2 | Renin-inhibiting amino acid derivatives | MERCK PATENT GmbH (DE) | 1989-10-18 | — | — | EP | disclosed |